ArticleACS omega2026
Surface Modification of Titanium with EGCG and Hexamethylenediamine Coating for BMP‑2 Grafting: An Investigation of Osteogenic Properties.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osseointegration between titanium implants and surrounding bone is essential for the long-term success of implant surgery. However, mechanical injury during implantation can induce local oxidative stress, which compromises peri-implant osteogenesis. In this study, we developed a multifunctional titanium surface by codepositing epigallocatechin gallate (EGCG) and hexamethylenediamine (HD) to form a phenolic-amine coating with tunable amino-group density, followed by covalent grafting of bone morphogenetic protein-2 (BMP-2) via carbodiimide chemistry. Surface characterization confirmed the successful fabrication of the coatings, which exhibited improved hydrophilicity and pronounced radical-scavenging activity. In vitro experiments showed that the modified surfaces promoted osteoblast adhesion and spreading and enhanced osteogenic differentiation, as demonstrated by increased alkaline phosphatase (ALP) activity, enhanced extracellular matrix mineralization, and upregulated expression of osteogenesis-related genes and proteins, including Runx2, ALP, and OPN. Among the tested groups, the coating prepared with EGCG and HD at 0.4 mg/mL followed by BMP-2 grafting showed the strongest osteogenic performance. These findings suggest that the EGCG/HD/BMP-2 coating is a promising surface-engineering strategy for titanium implants by simultaneously improving the oxidative microenvironment and promoting osteogenesis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.